Structural genomics of the human dopamine receptor system.
Xu, P., Huang, S., Krumm, B.E., Zhuang, Y., Mao, C., Zhang, Y., Wang, Y., Huang, X.P., Liu, Y.F., He, X., Li, H., Yin, W., Jiang, Y., Zhang, Y., Roth, B.L., Xu, H.E.(2023) Cell Res 33: 604-616
- PubMed: 37221270 
- DOI: https://doi.org/10.1038/s41422-023-00808-0
- Primary Citation of Related Structures:  
8IRR, 8IRS, 8IRT, 8IRU, 8IRV - PubMed Abstract: 
The dopaminergic system, including five dopamine receptors (D1R to D5R), plays essential roles in the central nervous system (CNS); and ligands that activate dopamine receptors have been used to treat many neuropsychiatric disorders, including Parkinson's Disease (PD) and schizophrenia. Here, we report cryo-EM structures of all five subtypes of human dopamine receptors in complex with G protein and bound to the pan-agonist, rotigotine, which is used to treat PD and restless legs syndrome. The structures reveal the basis of rotigotine recognition in different dopamine receptors. Structural analysis together with functional assays illuminate determinants of ligand polypharmacology and selectivity. The structures also uncover the mechanisms of dopamine receptor activation, unique structural features among the five receptor subtypes, and the basis of G protein coupling specificity. Our work provides a comprehensive set of structural templates for the rational design of specific ligands to treat CNS diseases targeting the dopaminergic system.
Organizational Affiliation: 
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.